Abstract
Pouchitis is the most common long-term complication of ileal pouch-anal anastomosis in patients with underlying ulcerative colitis. Clinical symptoms of pouchitis are not specific, and they can be caused by other conditions such as rectal cuff inflammation and irritable pouch syndrome. Therefore, to make an accurate diagnosis, endoscopic evaluation together with symptom assessment is necessary. Among five available treat-first and test-first strategies, the initial approach with pouch endoscopy without histology was the most cost-effective strategy for the diagnosis of pouchitis. On the basis of clinical course, pouchitis can be classified into acute, relapsing and chronic forms. Pouchitis can also be classified into three categories based on the response to antibacterial therapy: (i) antibacterial-responsive; (ii) antibacterial-dependent; and (iii) antibacterial-resistant. Metronidazole and ciprofloxacin are both effective in treating acute pouchitis. Although antibacterial therapy can induce and maintain remission, probiotics such as VSL#3 can also be used as to maintain clinical remission and prevent relapse in patients with relapsing or chronic pouchitis. For patients with chronic pouchitis that is resistant to antibacterials, therapy with anti-inflammatory agents and immunomodulators is often required.
Similar content being viewed by others
Notes
Use of tradenames is for identification purposes only and does not imply endorsement.
References
Sandborn WJ. Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 1994; 107: 1856–60
Zuccaro G, Fazio VW, Church JM, et al. Pouch ileitis. Dig Dis Sci 1989; 34: 1505–10
Fazio VW, Ziv Y, Church JM, et al. Heal pouch-anal anastomosis complications and function in 1005 patients. Ann Surg 1995; 222: 120–7
Penna C, Dozois R, Tremaine W, et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996; 38: 234–9
Shepherd NA, Hulten L, Tytgat GNJ, et al. Workshop: pouchitis. Int J Colorectal Dis 1989; 4: 205–29
Lohmuller JL, Perberton JH, Dozois RR, et al. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 1990; 211: 622–9
Penna C, Tiret E, Kartheuser A, et al. Function of ileal J pouch-anal anastomosis in patients with familial adenomatous polyposis. Br J Surg 1993; 80: 765–7
Tjandra JJ, Fazio VW, Church JM, et al. Similar functional results after restorative proctocolectomy in patients with familial adenomatous polyposis and mucosal ulcerative colitis. Am J Surg 1993; 165: 322–5
Dozois RR, Goldberg SM, Rothenberger DA, et al. Workshop: pouchitis. Int J Colorectal Dis 1986; 1: 2–19
Schmidt CM, Lazenby AJ, Hendrickson RJ, et al. Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure. Ann Surg 1998; 227: 654–65
Meagher AP, Farouk R, Dozois RR, et al. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcomes in 1310 patients. Br J Surg 1998; 85: 800–3
Yang T, Oresland T, Jarnerot G, et al. Perinuclear antineutrophil cytoplasmic antibody in pouchitis after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Scand J Gastroenterol 1996; 31: 594–8
Sandborn WJ, Landers CJ, Tremaine WJ, et al. Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis. Am J Gastroenterol 1995; 90: 740–7
Fleshner PR, Vasiliauskas EA, Kam LY, et al. High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut 2001; 49: 671–7
Shen B, Achkar J-P, Lashner BA, et al. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology 2001; 121: 261–7
Kmiot WA, Hesslewood SR, Smith N, et al. Evaluation of the inflammatory infiltrate in pouchitis with 111In-labeled granulocytes. Gastroenterology 1993; 104: 981–8
Moskowitz RL, Shepherd NA, Nicholls RJ. An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorectal Dis 1986; 1: 167–74
Petras RE. Role of the pathologist in evaluating chronic pouchitis. In: Bayless TM, Hanauer SB, editors. Advanced therapy of inflammatory bowel disease. 1st ed. Hamilton, (ON): BC Decker, 2001: 229–32
Pemberton JH. The problem with pouchitis [editorial]. Gastroenterology 1993; 104: 1209–11
Shen B, Achkar JP, Lashner BA, et al. Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol 2002; 97: 972–7
Heuschen UA, Autschbach F, Allemeyer EH, et al. Long-term follow-up after ileoanal pouch procedure: algorithm for diagnosis, classification, and management of pouchitis. Dis Colon Rectum 2001; 44: 487–99
Sandborn WJ, Tremaine WJ, Batts KP, et al. Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index. Mayo Clin Proc 1994; 69: 409–15
Gionchetti P, Rizzello F, Venturi A, et al. Antibiotic combination therapy in patients with chronic, treatment resistant pouchitis. Aliment Pharmacol Ther 1999; 13: 713–8
Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 305–9
Tremaine WJ, Sandborn WJ, Wolff BG, et al. Bismuth carbomer foam enemas for active chronic pouchitis: a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther 1997; 11: 1041–6
Shen B, Achkar JP, Lashner BA, et al. A randomized trial of ciprofloxacin and metronidazole in treating acute pouchitis. Inflamm Bowel Dis 2001; 7: 301–5
Gionchetti P, Rizzollo F, Venturi A, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double blind, placebo controlled trial [abstract]. Gastroenterology 2000; 118: A1214
Sandborn WJ, Tremaine WJ, Batts KP, et al. Fecal bile acids, short-chain fatty acids, and bacteria after ileal pouch-anal anastomosis do not differ in patients with pouchitis. Dig Dis Sci 1995; 40: 1474–83
Sambuelli A, Boerr L, Negreira S, et al. Budesonide enema in pouchitis: a double-blinded, double dummy, controlled trial. Aliment Pharmacol Ther 2002; 16: 27–34
Sandborn WJ. Pouchitis: risk factors, frequency, natural history, classification, and public health prospective. In: McLeod RS, Martin F, Sutherland LR, et al., editors. Trends in inflammatory bowel disease 1996. Lancaster, UK: Kluwer Academic Publishers, 1997: 51–63
Sandborn WJ. Pouchitis in the Kock continent ileostomy and the ileoanal pouch. In: Kirsner JB, editor. Inflammatory bowel disease. 5th ed. Philadelphia (PA): WB Saunders Company, 1999: 736–47
Shen B, Lashner BA, Achkar JP, et al. Modified pouchitis disease activity index (mPDAI): a new approach to the diagnosis of pouchitis. Dis Colon Rectum. In press
Shen B, Shermock KM, Achkar JP, et al. A cost-effectiveness analysis of diagnostic strategies in symptomatic patients with ileal pouch-anal anastomosis [abstract]. Am J Gastroenterol 2001; 96: A975
Ricart E, Panccione R, Loftus EV, et al. Successful management of Crohn disease of the ileoanal pouch with infliximab. Gastroenterology 1999; 117: 429–32
Madden MV, McIntyre AS, Nicholls RJ. Double-blinded crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 1994; 39: 1193–6
Mignon M, Stettier C, Philips SF. Pouchitis: a poorly understood entity. Dis Colon Rectum 1995; 38: 100–3
Sartor RB. Probiotics in chronic pouchitis: restoring luminal microbial balance. Gastroenterology 2000; 119: 584–5
Hurst RD, Molinari M, Chung TP, et al. Prospective study of the incidence, timing, and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg 1996; 131: 497–502
Mowschenson PM, Critchlow JF, Peppercorn MA. Ileoanal pouch operation: long-term outcome with or without diverting ileostomy. Arch Surg 2000; 135: 463–5
Hurst RD, Chung TP, Rubin M, et al. Implications of acute pouchitis on the long-term functional results after restorative proctocolectomy. Inflamm Bowel Dis 1998; 4: 280–4
Madiba TE, Bartolo DC. Pouchitis following restorative proctocolectomy for ulcerative colitis: incidence and therapeutic outcome. J R Coll Surg Edinb 2001; 46: 334–7
Wischmeyer P, Pemberton JH, Philips SF. Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study. Mayo Clin Proc 1993; 68: 978–81
Gionchetti P, Rizzello R, Venturi A, et al. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Aliment Pharmacol Ther 1999; 13: 713–8
Mimura T, Rizzello R, Helwig U, et al. Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther 2002; 16: 909-17
Acknowledgements
This manuscript in supported by an American College of Gastroenterology Clinical Research Grant.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shen, B. Diagnosis and Treatment of Patients with Pouchitis. Drugs 63, 453–461 (2003). https://doi.org/10.2165/00003495-200363050-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-200363050-00002